213 related articles for article (PubMed ID: 31337239)
21. Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod.
Tutrone WD; Saini R; Caglar S; Weinberg JM; Crespo J
Cutis; 2003 May; 71(5):365-70. PubMed ID: 12769403
[TBL] [Abstract][Full Text] [Related]
22. Actikerall™ (5-Fluorouracil 0.5% and Salicylic Acid 10%) Topical Solution for Patient-directed Treatment of Actinic Keratoses.
Nguyen HP; Rivers JK
Skin Therapy Lett; 2016 May; 21(3):1-3. PubMed ID: 27223248
[TBL] [Abstract][Full Text] [Related]
23. Reducing unpleasant side effects of topical 5-Fluorouracil treatment for actinic keratosis: a randomized controlled trial.
Maarouf M; Kromenacker BW; Brucks ES; Hendricks A; Shi VY
J Dermatolog Treat; 2020 Mar; 31(2):175-179. PubMed ID: 30821548
[No Abstract] [Full Text] [Related]
24. 5-Fluorouracil-induced exacerbation of rosacea.
Haddock ES; Cohen PR
Dermatol Online J; 2016 Nov; 22(11):. PubMed ID: 28329576
[TBL] [Abstract][Full Text] [Related]
25. Treating skin cancer with topical cream.
Micali G; Lacarrubba F; Dinotta F; Massimino D; Nasca MR
Expert Opin Pharmacother; 2010 Jun; 11(9):1515-27. PubMed ID: 20408746
[TBL] [Abstract][Full Text] [Related]
26. 5% fluorouracil chemowraps in the management of widespread lower leg solar keratoses and squamous cell carcinoma.
Tallon B; Turnbull N
Australas J Dermatol; 2013 Nov; 54(4):313-6. PubMed ID: 23651243
[TBL] [Abstract][Full Text] [Related]
27. Topical kinase inhibitors induce regression of cutaneous squamous cell carcinoma.
Yang X; Daifallah AEM; Shankar S; Beer J; Marshall C; Dentchev T; Seykora F; D'Armas S; Hahn J; Lee V; Sabry HH; Farag AM; Seykora JT
Exp Dermatol; 2019 May; 28(5):609-613. PubMed ID: 30762245
[TBL] [Abstract][Full Text] [Related]
28. Relative efficacy of 5-fluorouracil compared with other treatments among patients with actinic keratosis: A network meta-analysis.
Wu Y; Tang N; Cai L; Li Q
Dermatol Ther; 2019 May; 32(3):e12822. PubMed ID: 30638294
[TBL] [Abstract][Full Text] [Related]
29. Impact of topical fluorouracil cream on costs of treating keratinocyte carcinoma (nonmelanoma skin cancer) and actinic keratosis.
Yoon J; Phibbs CS; Chow A; Weinstock MA;
J Am Acad Dermatol; 2018 Sep; 79(3):501-507.e2. PubMed ID: 29505863
[TBL] [Abstract][Full Text] [Related]
30. The paradigm shift in treating actinic keratosis: a comprehensive strategy.
Stockfleth E
J Drugs Dermatol; 2012 Dec; 11(12):1462-7. PubMed ID: 23377517
[TBL] [Abstract][Full Text] [Related]
31. Use of reflectance confocal microscopy to evaluate 5-fluorouracil 0.5%/salicylic acid 10% in the field-directed treatment of subclinical lesions of actinic keratosis: subanalysis of a Phase III, randomized, double-blind, vehicle-controlled trial.
Ulrich M; Reinhold U; Falqués M; Rodriguez Azeredo R; Stockfleth E
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):390-396. PubMed ID: 28960520
[TBL] [Abstract][Full Text] [Related]
32. Safety of topical interventions for the treatment of actinic keratosis.
Koch EAT; Wessely A; Steeb T; Berking C; Heppt MV
Expert Opin Drug Saf; 2021 Jul; 20(7):801-814. PubMed ID: 33834933
[No Abstract] [Full Text] [Related]
33. Topical pharmacotherapy for skin cancer: part II. Clinical applications.
Micali G; Lacarrubba F; Nasca MR; Ferraro S; Schwartz RA
J Am Acad Dermatol; 2014 Jun; 70(6):979.e1-12; quiz 9912. PubMed ID: 24831325
[TBL] [Abstract][Full Text] [Related]
34. Squamous cell carcinomas of the lower limbs in African American women.
Woolery-Lloyd H; Elsaie ML; Avashia N
J Am Acad Dermatol; 2011 Jul; 65(1):221-3. PubMed ID: 21679826
[No Abstract] [Full Text] [Related]
35. Effect of ingenol mebutate on actinic keratosis in a Korean population: A prospective clinical, dermoscopic and histopathological study from a single center.
Kim JS; Woo YR; Kim M; Park HJ
J Dermatol; 2018 Nov; 45(11):1324-1330. PubMed ID: 30260493
[TBL] [Abstract][Full Text] [Related]
36. The efficacy and safety of topical 5% 5-fluorouracil in renal transplant recipients for the treatment of actinic keratoses.
Ingham AI; Weightman W
Australas J Dermatol; 2014 Aug; 55(3):204-8. PubMed ID: 24627952
[TBL] [Abstract][Full Text] [Related]
37. Randomized, vehicle-controlled trials of topical 5-fluorouracil therapy for actinic keratosis treatment: an overview.
Rahvar M; Lamel SA; Maibach HI
Immunotherapy; 2012 Sep; 4(9):939-45. PubMed ID: 23046237
[TBL] [Abstract][Full Text] [Related]
38. Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial.
Pomerantz H; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin G; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri J; Lew R; Weinstock MA;
JAMA Dermatol; 2015 Sep; 151(9):952-60. PubMed ID: 25950503
[TBL] [Abstract][Full Text] [Related]
39. In vivo Confocal Laser Microscopy for monitoring of actinic keratosis treatment: a comparison with histopathologic assessment after treatment with topical 5% 5-fluorouracil.
Ishioka P; Maia M; Rodrigues SB; Lellis RF; Hirata SH
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1155-1163. PubMed ID: 29178474
[TBL] [Abstract][Full Text] [Related]
40. Treatment of Actinic Keratoses: A Randomized Split-Site Approach Comparison of Sequential 5-Fluorouracil and 5-Aminolevulinic Acid Photodynamic Therapy to 5-Aminolevulinic Acid Photodynamic Monotherapy.
Pei S; Kaminska ECN; Tsoukas MM
Dermatol Surg; 2017 Sep; 43(9):1170-1175. PubMed ID: 28562434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
